Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

0RQE

Idorsia (0RQE)

Idorsia Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RQE
DateTimeSourceHeadlineSymbolCompany
07/18/202411:45AMUK RegulatoryInvitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference callLSE:0RQEIdorsia Ltd
07/01/20241:00AMUK RegulatoryIdorsia’s JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertensionLSE:0RQEIdorsia Ltd
06/28/202411:45AMUK RegulatoryHigher cantonal composition authority issues written court decision in respect to the amendments to the terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
06/25/202411:45AMUK RegulatoryHigher cantonal composition authority approved the amendments to the terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
06/21/20241:00AMUK RegulatoryIdorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’ categoryLSE:0RQEIdorsia Ltd
06/13/20245:00AMUK RegulatoryIdorsia holds its Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
06/03/20241:00AMUK RegulatoryNew data with daridorexant to be presented at SLEEP 2024LSE:0RQEIdorsia Ltd
06/03/20241:00AMUK RegulatoryNew data with daridorexant to be presented at SLEEP 2024LSE:0RQEIdorsia Ltd
05/31/20241:00AMUK RegulatoryData from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024LSE:0RQEIdorsia Ltd
05/31/20241:00AMUK RegulatoryData from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024LSE:0RQEIdorsia Ltd
05/23/20241:00AMUK RegulatoryIdorsia issues invitation to the 2024 Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
05/23/20241:00AMUK RegulatoryIdorsia issues invitation to the 2024 Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
05/21/20241:00AMUK RegulatoryIdorsia announces changes to Idorsia Executive Committee and Board of DirectorsLSE:0RQEIdorsia Ltd
05/21/20241:00AMUK RegulatoryIdorsia announces changes to Idorsia Executive Committee and Board of DirectorsLSE:0RQEIdorsia Ltd
05/21/202412:50AMUK RegulatoryIdorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigorLSE:0RQEIdorsia Ltd
05/21/202412:50AMUK RegulatoryIdorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigorLSE:0RQEIdorsia Ltd
05/21/202412:40AMUK RegulatoryIdorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable valueLSE:0RQEIdorsia Ltd
05/21/202412:40AMUK RegulatoryIdorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable valueLSE:0RQEIdorsia Ltd
05/14/202411:45AMUK RegulatoryInvitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference callLSE:0RQEIdorsia Ltd
05/14/202411:45AMUK RegulatoryInvitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference callLSE:0RQEIdorsia Ltd
05/06/202412:35PMUK RegulatoryBondholders approve amended terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
05/06/202412:35PMUK RegulatoryBondholders approve amended terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
05/01/202412:00PMUK RegulatoryIdorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bondLSE:0RQEIdorsia Ltd
05/01/202412:00PMUK RegulatoryIdorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bondLSE:0RQEIdorsia Ltd
04/26/20241:00AMUK RegulatoryJERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertensionLSE:0RQEIdorsia Ltd
04/26/20241:00AMUK RegulatoryJERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertensionLSE:0RQEIdorsia Ltd
04/23/20241:00AMUK RegulatoryIdorsia publishes an invitation to a bondholder meetingLSE:0RQEIdorsia Ltd
04/23/20241:00AMUK RegulatoryIdorsia publishes an invitation to a bondholder meetingLSE:0RQEIdorsia Ltd
04/17/20241:00AMUK RegulatoryIdorsia publishes a Financial Status required for an upcoming bondholder meetingLSE:0RQEIdorsia Ltd
04/17/20241:00AMUK RegulatoryIdorsia publishes a Financial Status required for an upcoming bondholder meetingLSE:0RQEIdorsia Ltd
 Showing the most relevant articles for your search:LSE:0RQE

Your Recent History

Delayed Upgrade Clock